|
Pharmaceutical industry veteran Phill Dritsas is President of Fleming Pharmaceuticals. As president, Mr. Dritsas' main responsibility is to lead new corporate and product strategy, prepare for pending approval of new products in clinical development with the U.S. Food and Drug Administration, and dramatically expand the company's marketing and selling capabilities.
Mr. Dritsas is in prime position to lead Fleming to its next stage of development. During his more than two decades in the pharmaceutical industry, Mr. Dritsas launched major brands and generic entries, prescription as well as over-the-counter, and helped grow his former company from sales of a few million to a notable pharmaceutical company.
"What attracted me to Fleming were the people and the pipeline of future products. I was impressed with the high caliber of talent the company has been able to attract and retain, and the opportunity to expand through NDA products pending approval by the FDA." Mr. Dritsas says. "We have all components in place to expand significantly within our established brands and new prescription products."
He believes that challenging convention, combined with honesty and integrity, is essential to running a successful entrepreneurial business. A hands-on approach often has him rolling up his sleeves and working besides all levels of personnel.
Mr. Dritsas holds a Master's degree in Health and Human Services and in Management from St. Mary's University in Minneapolis. He received his Bachelor's Degree from the University of Minnesota. Mr. Dritsas, formerly Vice President of Sales and Marketing for Upsher Smith Laboratories Inc. of Maple Grove, Minnesota, brings to Fleming more than 22 years of experience in the pharmaceutical industry.
When he is not working, Mr. Dritsas enjoys spending as much possible time in the company of his four children, ranging in age from 11 to 19 years.
| 